Add to ORKGAims Interval cancer is a key factor that influences the effectiveness of a cancer screening pro-gram. To evaluate the impact of interval cancer on the effectiveness of endoscopic screen-ing, the survival rates of patients with interval cancer were analyzed. Methods We performed gastric cancer-specific and all-causes survival analyses of patients with screen-detected cancer and patients with interval cancer in the endoscopic screening group and radiographic screening group using the Kaplan-Meier method. Since the screen-ing interval was 1 year, interval cancer was defined as gastric cancer detected within 1 year after a negative result. A Cox proportional hazards model was used to investigate the risk factors associated with gastric cancer-...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background: Between 2000 and 2007, a demonstration pilot of biennial guaiac faecal occult blood test...
Interval cancer is a key factor that influences the effectiveness of a cancer screening program. To ...
BACKGROUND/AIMS: Early gastric cancer (EGC) can be treated by endoscopic resection, which results in...
Background: The European randomised study of screening for prostate cancer (ERSPC) was initiated to ...
For many years, members of medical profession have believed that the shorter symptoms to diagnosis i...
Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the second ...
Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the second ...
Introduction: Mammographic density (MD) is the strongest risk factor for breast cancer. It is also s...
Purpose: This study aimed to analyze the effect of screening by using endoscopy on the diagnosis and...
PURPOSETo assess interval cancer rate in a large, prospective digital breast tomosynthesis (DBT) scr...
AIMS: Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the s...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background/Aims: Interval gastric cancer (IGC) is defined as cancer that is diagnosed between the ti...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background: Between 2000 and 2007, a demonstration pilot of biennial guaiac faecal occult blood test...
Interval cancer is a key factor that influences the effectiveness of a cancer screening program. To ...
BACKGROUND/AIMS: Early gastric cancer (EGC) can be treated by endoscopic resection, which results in...
Background: The European randomised study of screening for prostate cancer (ERSPC) was initiated to ...
For many years, members of medical profession have believed that the shorter symptoms to diagnosis i...
Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the second ...
Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the second ...
Introduction: Mammographic density (MD) is the strongest risk factor for breast cancer. It is also s...
Purpose: This study aimed to analyze the effect of screening by using endoscopy on the diagnosis and...
PURPOSETo assess interval cancer rate in a large, prospective digital breast tomosynthesis (DBT) scr...
AIMS: Although the incidence of gastric cancer has decreased in the last 3 decades, it remains the s...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background/Aims: Interval gastric cancer (IGC) is defined as cancer that is diagnosed between the ti...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background: In patients with gastric or gastroesophageal junction (GEJ) cancer treated with curative...
Background: Between 2000 and 2007, a demonstration pilot of biennial guaiac faecal occult blood test...